Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA.

Neurol Neuroimmunol Neuroinflamm · 2017 · PMC5550381 · PMID 28828394

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A similar pattern of reduced BVL was observed in patients receiving teriflunomide 7 mg, although results did not reach statistical significance in the subgroup of patients without 12- or 24-week CDW from baseline to year 2 (figure e-4, A and B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.